Global Sample Preparation Automation Instruments Market Size, Share and Trends Analysis Report – Industry Overview and Forecast to 2033

Sample Preparation Automation Instruments Market Size

• The global sample preparation automation instruments market size was valued at USD 1.02 billion in 2025 and is expected to reach USD 2.12 billion by 2033, at a CAGR of 9.60% during the forecast period
• The market growth is largely fueled by the rising adoption of automation in laboratory workflows, driven by the need for high-throughput processing, improved accuracy, reproducibility, and reduced manual errors across clinical diagnostics, genomics, proteomics, and drug discovery applications
• Furthermore, increasing investments in life sciences research, expanding pharmaceutical and biotechnology pipelines, and the growing demand for efficient, standardized, and scalable sample preparation solutions are positioning automation instruments as critical components of modern laboratories. These converging factors are accelerating market adoption and significantly boosting overall industry growth

Sample Preparation Automation Instruments Market Analysis

• Sample preparation automation instruments, which enable standardized and efficient processing of biological, chemical, and environmental samples, are increasingly vital components of modern laboratory workflows across clinical, research, and industrial settings due to their ability to enhance accuracy, reproducibility, throughput, and operational efficiency
• The escalating demand for sample preparation automation is primarily fueled by the growing volume of complex samples, increasing adoption of high-throughput analytical techniques, rising focus on minimizing manual errors, and expanding use of automated workflows in genomics, proteomics, clinical diagnostics, and drug discovery
• North America dominated the global sample preparation automation instruments market with the largest revenue share of 40.8% in 2025, supported by strong life sciences and biotechnology R&D investments, advanced laboratory infrastructure, early adoption of automation technologies, and the significant presence of leading pharmaceutical, biotechnology, and diagnostics companies, particularly in the U.S.
• Asia-Pacific is expected to be the fastest growing region during the forecast period due to rapid expansion of pharmaceutical and biotechnology industries, increasing research funding, rising numbers of diagnostic laboratories, and growing adoption of automated laboratory solutions across emerging economies
• Instruments segment dominated the sample preparation automation instruments market with a revenue share of 48.2% in 2025, driven by the widespread deployment of automated systems and robotic platforms that serve as the core infrastructure for sample preparation workflows across clinical diagnostics, genomics, drug discovery, and research applications

Report Scope and Sample Preparation Automation Instruments Market Segmentation 

Sample Preparation Automation Instruments Market Trends

“Integration of Automation with High-Throughput and Multi-Omics Workflows”

• A significant and accelerating trend in the global sample preparation automation instruments market is the increasing integration of automated systems with high-throughput and multi-omics workflows, enabling laboratories to process large sample volumes with greater accuracy, consistency, and efficiency
• For instance, several leading automation platform providers are introducing sample preparation systems specifically designed to integrate seamlessly with next-generation sequencing and proteomics workflows, allowing end users to streamline complex analytical pipelines
• Automation integration enables features such as standardized sample handling, reduced variability, and improved reproducibility, which are critical for genomics, proteomics, and metabolomics applications where data quality and consistency are essential for downstream analysis
• The seamless integration of automated sample preparation instruments with laboratory information management systems and analytical instruments facilitates centralized workflow control, data traceability, and improved operational transparency across laboratories
• This trend toward more intelligent, scalable, and workflow-integrated sample preparation solutions is reshaping laboratory expectations, prompting manufacturers to develop flexible and modular systems compatible with diverse applications and sample types
• The demand for automation platforms that support high-throughput and multi-omics research is growing rapidly across pharmaceutical, biotechnology, and clinical research laboratories as organizations increasingly prioritize speed, scalability, and data reliability
• Growing interest in AI-assisted workflow optimization and predictive maintenance features is further influencing product development, as laboratories aim to improve uptime, efficiency, and long-term system performance

Sample Preparation Automation Instruments Market Dynamics

Driver

“Rising Demand for Efficiency and Standardization in Laboratory Workflows”

• The increasing need for efficiency, accuracy, and standardization in laboratory workflows, combined with growing sample volumes, is a key driver accelerating demand for sample preparation automation instruments
• For instance, in 2025, several pharmaceutical and biotechnology companies expanded investments in automated laboratory infrastructure to support large-scale drug discovery and genomics research, highlighting the shift toward automation-driven operations
• As laboratories handle more complex and time-sensitive samples, automation instruments help reduce manual errors, improve reproducibility, and ensure compliance with stringent quality and regulatory requirements
• Furthermore, the growing adoption of high-throughput analytical techniques in clinical diagnostics and life sciences research is making automated sample preparation an essential component of modern laboratory ecosystems
• The ability to shorten turnaround times, optimize labor utilization, and support scalable research and diagnostic operations is significantly propelling the adoption of sample preparation automation across multiple end-user segments
• Rising shortages of skilled laboratory personnel are further driving demand for automation, as laboratories seek to maintain productivity while reducing reliance on manual labor
• Increasing regulatory emphasis on data integrity and traceability is also encouraging laboratories to adopt automated sample preparation systems that support standardized and auditable workflows

Restraint/Challenge

“High Initial Investment and Integration Complexity”

• Concerns related to the high upfront cost of automated sample preparation instruments and the complexity of integrating them into existing laboratory infrastructure present a key challenge to broader market adoption
• For instance, smaller laboratories and academic research institutions may hesitate to adopt advanced automation platforms due to budget constraints and limited technical expertise for system integration
• Addressing these challenges requires manufacturers to focus on cost-effective system designs, modular platforms, and comprehensive training and support services to ease implementation and improve return on investment
• While automation delivers long-term efficiency gains, the perceived financial and operational burden during the initial deployment phase can still deter adoption, particularly in resource-constrained settings
• Overcoming these barriers through flexible pricing models, scalable solutions, and simplified integration with existing laboratory workflows will be critical for sustaining long-term market growth
• Compatibility issues between automation platforms and legacy laboratory instruments can further complicate adoption and increase implementation timelines
• Limited awareness and resistance to workflow changes among laboratory staff may also slow adoption, requiring targeted education and change-management initiatives

Sample Preparation Automation Instruments Market Scope

The market is segmented on the basis of component, technology, application, and end user.

• By Component

On the basis of component, the global sample preparation automation instruments market is segmented into instruments, consumables, software & services, and accessories. The instruments segment dominated the market in 2025 with a market share of 48.2%, driven by the critical role automated platforms play in laboratory workflows across clinical diagnostics, genomics, proteomics, and drug discovery. Instruments such as automated liquid handlers, extraction systems, and robotic workstations form the backbone of automation, enabling high-throughput processing, improved reproducibility, and reduced human error. Laboratories prioritize investments in instruments to modernize infrastructure, meet rising sample volumes, and comply with stringent quality standards. The high capital value of these systems further contributes to their larger revenue share compared to other components.

The consumables segment is expected to be the fastest growing during the forecast period, fueled by their recurring usage across routine and high-volume testing workflows. Automated sample preparation relies heavily on proprietary kits, reagents, cartridges, plates, and columns, which must be replenished frequently. Growth in clinical diagnostics, NGS-based testing, and pharmaceutical R&D is directly increasing consumable demand. In addition, vendor-specific consumables designed for optimized performance with automated instruments are driving repeat purchases and long-term revenue generation.

• By Technology

On the basis of technology, the market is segmented into automated systems, robotic platforms, manual, and microfluidic technologies. The automated systems segment dominated the market in 2025, supported by widespread adoption across pharmaceutical, biotechnology, and clinical laboratories. Automated systems offer a balance of scalability, reliability, and ease of integration into existing laboratory workflows. They are extensively used for routine sample preparation tasks, providing consistency and faster turnaround times while reducing labor dependency. Their versatility across multiple applications has made them the preferred choice for laboratories transitioning from manual to automated processes.

The microfluidic technologies segment is anticipated to witness the fastest growth rate over the forecast period, driven by increasing demand for miniaturized, low-volume, and high-precision workflows. Microfluidic platforms enable reduced reagent consumption, faster processing, and enhanced sensitivity, making them highly attractive for genomics, proteomics, and point-of-care research applications. Growing interest in decentralized testing, personalized medicine, and advanced analytical techniques is accelerating adoption. Continued innovation and declining costs are further supporting the rapid growth of microfluidic-based sample preparation solutions.

• By Application

On the basis of application, the market is segmented into clinical diagnostics, genomics & next-generation sequencing (NGS), proteomics & metabolomics, drug discovery & development, environmental testing, food safety & quality testing, forensic analysis, and other applications. The genomics & next-generation sequencing (NGS) segment dominated the market in 2025, driven by the rapid expansion of precision medicine, population genomics, and large-scale sequencing projects. Automated sample preparation is essential in NGS workflows to handle large sample volumes while maintaining accuracy and consistency. Pharmaceutical companies, research institutions, and diagnostic labs increasingly rely on automation to meet throughput demands and ensure reproducible sequencing results. The growing use of NGS in oncology, rare disease diagnosis, and infectious disease surveillance further strengthens this segment’s dominance.

The clinical diagnostics segment is expected to be the fastest growing application during the forecast period, supported by rising adoption of molecular diagnostics and automated testing platforms. Clinical laboratories are increasingly automating sample preparation to reduce turnaround times, improve diagnostic accuracy, and manage growing patient sample loads. The shift toward standardized and automated diagnostic workflows, particularly in infectious disease testing and personalized diagnostics, is accelerating demand. Regulatory pressure for consistent and traceable diagnostic processes is also contributing to rapid growth in this segment.

• By End User

On the basis of end user, the market is segmented into pharmaceutical & biotechnology companies, clinical and diagnostic laboratories, academic & research institutions, food testing labs, and other end users. The pharmaceutical & biotechnology companies segment dominated the market in 2025, owing to substantial investments in drug discovery, biologics development, and genomics research. These organizations handle large volumes of complex samples and require automated solutions to improve efficiency, reproducibility, and scalability. Sample preparation automation supports high-throughput screening, biomarker discovery, and preclinical research, making it a critical component of pharma and biotech R&D infrastructure. Strong funding pipelines and continuous innovation further reinforce this segment’s leadership.

The clinical and diagnostic laboratories segment is projected to be the fastest growing end-user category over the forecast period, driven by rising diagnostic testing volumes and increased adoption of molecular and automated diagnostic techniques. Clinical labs are under pressure to deliver faster and more reliable results while managing labor shortages and regulatory compliance. Automation helps standardize workflows, reduce manual intervention, and improve operational efficiency. The expanding role of diagnostics in disease prevention, early detection, and personalized treatment is expected to sustain strong growth in this segment.

Sample Preparation Automation Instruments Market Regional Analysis

• North America dominated the global sample preparation automation instruments market with the largest revenue share of 40.8% in 2025, supported by strong life sciences and biotechnology R&D investments, advanced laboratory infrastructure, early adoption of automation technologies, and the significant presence of leading pharmaceutical, biotechnology, and diagnostics companies, particularly in the U.S.
• Laboratories and research institutions in the region highly value the accuracy, reproducibility, and high-throughput capabilities offered by automated sample preparation systems, particularly for applications in genomics, clinical diagnostics, and drug discovery
• This widespread adoption is further supported by substantial R&D investments, advanced laboratory infrastructure, a high concentration of pharmaceutical and biotechnology companies, and early acceptance of automation solutions, establishing sample preparation automation instruments as essential tools across clinical, research, and industrial laboratories

U.S. Sample Preparation Automation Instruments Market Insight

The U.S. sample preparation automation instruments market captured the largest revenue share within North America in 2025, fueled by strong investments in life sciences R&D, widespread adoption of laboratory automation, and the presence of leading pharmaceutical, biotechnology, and diagnostics companies. Laboratories in the U.S. are increasingly prioritizing automated sample preparation to manage high testing volumes, improve reproducibility, and comply with stringent regulatory standards. The growing emphasis on genomics, precision medicine, and high-throughput drug discovery further propels market growth. Moreover, the rapid integration of automation with advanced analytical platforms and laboratory information systems continues to support market expansion.

Europe Sample Preparation Automation Instruments Market Insight

The Europe sample preparation automation instruments market is projected to expand at a notable CAGR during the forecast period, primarily driven by strong regulatory frameworks, increasing focus on standardized laboratory practices, and rising investments in biomedical research. The region’s growing emphasis on quality control, data integrity, and reproducibility is accelerating adoption of automated sample preparation systems. Increasing research activities across pharmaceuticals, biotechnology, and academic institutions are further supporting growth. The market is witnessing steady demand across clinical diagnostics, environmental testing, and food safety applications.

U.K. Sample Preparation Automation Instruments Market Insight

The U.K. sample preparation automation instruments market is anticipated to grow at a steady CAGR during the forecast period, driven by rising investments in genomics research, clinical diagnostics, and academic research programs. Increasing adoption of automation in laboratories to improve efficiency and reduce manual errors is supporting market growth. The U.K.’s strong research ecosystem, supported by government and private funding, is encouraging the deployment of advanced laboratory automation solutions. In addition, the expansion of molecular diagnostics and personalized medicine initiatives is expected to further stimulate demand.

Germany Sample Preparation Automation Instruments Market Insight

The Germany sample preparation automation instruments market is expected to expand at a healthy CAGR during the forecast period, supported by the country’s strong pharmaceutical, biotechnology, and industrial research base. Germany’s emphasis on precision engineering, quality standards, and technological innovation promotes the adoption of advanced automation solutions in laboratories. Increasing use of automated sample preparation in drug development, analytical testing, and industrial research is driving demand. The integration of automation with highly regulated laboratory environments aligns well with local requirements for accuracy, reliability, and data traceability.

Asia-Pacific Sample Preparation Automation Instruments Market Insight

The Asia-Pacific sample preparation automation instruments market is poised to grow at the fastest CAGR during the forecast period, driven by expanding pharmaceutical and biotechnology industries, increasing research funding, and rapid laboratory modernization across countries such as China, Japan, and India. Rising adoption of genomics, molecular diagnostics, and high-throughput testing is accelerating demand for automated sample preparation solutions. Government initiatives supporting biotechnology innovation and healthcare infrastructure development are further boosting market growth. In addition, increasing establishment of contract research organizations is contributing to wider adoption.

Japan Sample Preparation Automation Instruments Market Insight

The Japan sample preparation automation instruments market is gaining momentum due to the country’s strong focus on technological innovation, precision diagnostics, and advanced research capabilities. Japanese laboratories place a high emphasis on accuracy, efficiency, and automation to support genomics, proteomics, and pharmaceutical research. The integration of automated sample preparation systems with advanced analytical instruments is supporting market growth. Furthermore, increasing demand for standardized and high-quality laboratory workflows is reinforcing adoption across research and clinical settings.

India Sample Preparation Automation Instruments Market Insight

The India sample preparation automation instruments market accounted for a significant revenue share within Asia Pacific in 2025, driven by rapid expansion of pharmaceutical manufacturing, growing biotechnology research, and increasing adoption of advanced diagnostics. Rising investments in healthcare infrastructure, research laboratories, and academic institutions are accelerating demand for automated sample preparation systems. The growth of contract research and testing services, combined with government initiatives promoting innovation and self-reliance in life sciences, is further propelling market expansion. In addition, increasing affordability and availability of automation solutions are supporting wider adoption across diverse laboratory environments.

Sample Preparation Automation Instruments Market Share

The Sample Preparation Automation Instruments industry is primarily led by well-established companies, including:

• Thermo Fisher Scientific Inc (U.S.)
• Agilent Technologies Inc (U.S.)
• PerkinElmer, Inc, (U.S.)
• Beckman Coulter, Inc, (U.S.)
• Tecan Group Ltd, (Switzerland)
• Eppendorf AG (Germany)
• Hamilton Company (U.S.)
• Bio‑Rad Laboratories, Inc, (U.S.)
• Merck KGaA (Germany)
• Gilson, Inc, (U.S.)
• Analytik Jena GmbH, (Germany)
• Sartorius AG (Germany)
• Corning Incorporated (U.S.)
• Shimadzu Corporation (Japan)
• Waters Corporation (U.S.)
• Bruker Corporation (U.S.)
• Illumina, Inc, (U.S.)
• Covaris, Inc, (U.S.)

What are the Recent Developments in Global Sample Preparation Automation Instruments Market?

• In June 2025, Analytik Jena launched the ICprep series, a new automated sample preparation solution designed to automate up to 100 samples per sequence and streamline preparation for ion chromatography and related analyses, improving lab efficiency in environmental and industrial testing
• In May 2025, MGI Tech unveiled its next-generation automation portfolio at SLAS Europe 2025, including the PrepALL flexible liquid handling system and an enhanced MGISP-Smart 8 automated sample preparation platform. These innovations feature advanced robotics, modular design, and AI-assisted functionalities to help labs of all sizes streamline genomics, drug discovery, and synthetic biology workflows with higher precision and scalability
• In April 2025, QIAGEN announced plans to launch three new automated sample preparation instruments QIAsymphony Connect, QIAsprint Connect, and QIAmini aimed at enhancing laboratory automation, increasing throughput, and supporting workflows from high- to low-throughput settings. This strategic expansion highlights QIAGEN’s efforts to address diverse lab needs across clinical research, oncology, genomics, and pathogen detection
• In December 2024, QIAGEN announced that its EZ2 Connect automated sample preparation instrument reached over 1,000 placements worldwide, reinforcing its adoption in medium-volume labs for nucleic acid purification and reducing manual processing time, particularly for molecular biology and clinical research workflows
• In June 2024, Beckman Coulter Life Sciences launched the Biomek Echo One System, a new integrated automation platform that accelerates high-throughput genomic sample preparation by combining acoustic liquid handling with robotic liquid handlers, enabling streamlined library preparation steps such as extraction, fragmentation, ligation, and normalization to improve throughput and reduce manual intervention in NGS workflows

SKU-75293